IL-3Rα, GM-CSFRα, IL-2Rα, γc, c-kit, FLT3, and G-CSFR showed a wide range of expression levels, and all these receptors (except FLT3) showed significant correlations with certain clinical or cellular features of AML (Table 2). This evidence concerns the gene FLT3 and acute myeloid leukemia.